10.01.2017
DCL and its subsidiaries spend 153 billion to own 90% of charter capital of Euvipharm. According to Cuu Long Pharmaceutical (DCL), in 01.06.2017, DCL along with its subsidiaries Saigon VPC Pharmaceutical Limited Company completed the transaction of buying 90% charter capital of Euvipharm, the total value is153 billion. The seller is Valeant Pharmaceuticals International, Inc […]